Pharmaceutical giant Eli Lilly has initiated a major legal offensive, filing six lawsuits against American businesses accused of distributing unauthorized, black-market versions of its experimental obesity treatment, retatrutide. The legal action targets compounding pharmacies, medical spas, and online retailers that are allegedly marketing the drug to consumers before it has secured regulatory approval. Retatrutide is […]